Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer

NCT06732531 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Bladder Cancer
Non Muscle Invasive

Interventions

DRUG: BH011

Sponsor

Zhuhai Beihai Biotech Co., Ltd